ANIK - Anika Therapeutics Inc.

ANIK Stock Chart

ANIK Profile

Anika Therapeutics, Inc. is a pioneering company dedicated to advancing early intervention orthopedic care and joint preservation solutions worldwide. Specializing in osteoarthritis (OA) pain management, regenerative therapies, soft tissue repair, and bone-preserving joint technologies, the company operates across the United States, Europe, and other international markets. Anika Therapeutics develops, manufactures, and commercializes a comprehensive portfolio of products based on its proprietary hyaluronic acid (HA) technology platform.

Within its OA pain management product line, Anika offers Monovisc, Orthovisc, Cingal, and Hyvisc, which provide effective relief for osteoarthritis symptoms. The company's joint preservation and restoration products encompass a diverse range of approximately 150 bone-preserving joint technologies, sports medicine solutions for soft tissue repair, and orthopedic regenerative products. Additionally, Anika Therapeutics extends its HA-based technologies into non-orthopedic applications, including adhesion barriers, advanced wound care solutions, ophthalmic products, and treatments for ear, nose, and throat conditions.

Founded in 1983 and headquartered in Bedford, Massachusetts, Anika Therapeutics has established itself as a leader in the orthopedic and regenerative medicine sectors. With a commitment to innovation and patient-centric solutions, the company continues to drive advancements in joint care and expand its global presence through strategic partnerships and ongoing research and development initiatives.

ANIK Revenue Chart

ANIK Earnings

Analyst Ratings